Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Krytantek Ofteno vs Cosopt in Glaucoma/Ocular Hypertension
NCT01062971Phase 2Completed
- Sponsor
- Laboratorios Sophia
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timolol, brimonidine, dorzolamide in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Laboratorios Sophia. Started Feb 2006; status: completed.
02
Drugs
timololbrimonidinedorzolamide
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01062971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01062971.